Huntington's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Huntington's Disease, including details on genetics, causes, symptoms, treatment.

Volume 1 (2005), Issue 7 (July)

1. Dynein mutations impair autophagic clearance of aggregate-prone proteins.
   Nat Genet, 37(7): 771-6. [Abstract] [Full-text]
2. Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington's disease.
   Brain Res, 1050(1): 210-6. [Abstract] [Full-text]
3. p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease.
   Neuron, 47(1): 29-41. [Abstract] [Full-text]
4. The power of the dark side: Huntington's disease protein and p53 form a deadly alliance.
   Neuron, 47(1): 1-3. [Abstract] [Full-text]
5. Predictive genetic test decisions for Huntington's disease: elucidating the test/no-test dichotomy.
   J Health Psychol, 10(4): 597-612. [Abstract] [Full-text]
6. Neurodegenerative disorders: Parkinson's disease and Huntington's disease.
   J Neurol Neurosurg Psychiatry, 76(8): 1058-63. [Abstract] [Full-text]
7. Regional and subtype selective changes of neurotransmitter receptor density in a rat transgenic for the Huntington's disease mutation.
   J Neurochem, 94(3): 639-50. [Abstract] [Full-text]
8. Increased glutathione levels in cortical and striatal mitochondria of the R6/2 Huntington's disease mouse model.
   Neurosci Lett, 386(1): 63-8. [Abstract] [Full-text]
9. Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial.
   Neurology, 65(2): 286-92. [Abstract] [Full-text]

© 2005-2008 Huntington's Disease Research Today. All Rights Reserved.